Logo image
In vitro and in vivo suppression of GJB2 expression by RNA interference
Journal article   Open access   Peer reviewed

In vitro and in vivo suppression of GJB2 expression by RNA interference

Yukihide Maeda, Kunihiro Fukushima, Kazunori Nishizaki and Richard J H Smith
Human molecular genetics, Vol.14(12), pp.1641-1650
06/15/2005
DOI: 10.1093/hmg/ddi172
PMID: 15857852
url
https://doi.org/10.1093/hmg/ddi172View
Published (Version of record) Open Access

Abstract

Mutations in GJB2 (gap junction protein, beta-2) are the major cause of autosomal recessive non-syndromic hearing loss. A few allele variants of this gene also cause autosomal dominant non-syndromic hearing loss as a dominant-negative consequence of expression of the mutant protein. Allele-specific gene suppression by RNA interference (RNAi) is a potentially attractive strategy to prevent hearing loss caused by this mechanism. In this proof-of-principle study, we identified a potent GJB2-targeting short interfering RNA (siRNA) to post-transcriptionally silence the expression of the R75W allele variant of GJB2 in cultured mammalian cells. In a mouse model, this siRNA duplex selectively suppressed GJB2(R75W) expression by >70% of control levels, thereby preventing hearing loss. The level of endogenous murine Gjb2 expression was not affected. Our data show that RNAi can be used with specificity and efficiency in vivo to protect against hearing loss caused as a dominant-negative consequence of mutant gene expression.
Connexins - antagonists & inhibitors Humans Mice, Inbred C57BL Connexins - genetics Molecular Sequence Data Sequence Homology, Nucleic Acid Connexins - metabolism Connexin 26 Hearing Loss - genetics Hearing Loss - metabolism Animals Genes, Dominant RNA Interference Base Sequence Female Transcription, Genetic Mice Hearing Loss - prevention & control

Details

Logo image